Otonomy

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Otonomy sits in the top decile of US sponsors by registered trial count (#743 of 15,742 sponsors by registered trial count).

20 total trials none currently recruiting 16 completed top decile by trial count

Otonomy: 20 sponsored US clinical trials, none currently recruiting.

Otonomy sponsors 20 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 16 completed. 10 of these trials are in Phase 3-4 (later-stage) and 10 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Swimmer's Ear, with 1 trials.

Top-decile sponsor footprint

Otonomy ranks in the top decile of sponsors by registered trial count (#743 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 39/100

16 of 20 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (80.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

20 total, page 1 of 1

COMPLETED Phase 2

OTO-313 in Subjects With Unilateral Subjective Tinnitus

NCT04829214

COMPLETED Phase 1

OTO-413 in Subjects With Speech-in-Noise Hearing Impairment

NCT04129775

COMPLETED Phase 1

OTO-313 in Subjects With Subjective Tinnitus

NCT03918109

COMPLETED Phase 3

Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere's Disease

NCT03664674

TERMINATED Phase 2

Study of OTO-104 in Subjects at Risk From Cisplatin-Induced Hearing Loss

NCT02997189

TERMINATED Phase 3

A 6-Month Extension Study of OTO-104 in Meniere's Disease

NCT02768662

COMPLETED Phase 3

Phase 3 Study of OTO-201 in Acute Otitis Externa

NCT02801370

TERMINATED Phase 3

Study of OTO-104 in Subjects With Unilateral Meniere's Disease

NCT02717442

COMPLETED Phase 2

Dose Ranging Study of OTO-201 in AOMT

NCT02719158

TERMINATED Phase 3

A 6-Month Extension Study of OTO-104 in Meniere's Disease

NCT02706730

COMPLETED Phase 3

Study of OTO-104 in Subjects With Unilateral Meniere's Disease

NCT02612337

COMPLETED Phase 3

Open-Label Study of OTO-201 in Pediatric Subjects With a History of Otitis Media Requiring Tympanostomy Tubes

NCT02600559

COMPLETED Phase 2

OTO-201 for the Treatment of Otitis Externa

NCT02511561

COMPLETED Phase 2

Open-Label Study of OTO-201 for Treatment of AOMT

NCT02408796

COMPLETED Phase 3

Open-Label Study of OTO-201 for Middle Ear Effusion Evaluating Trans-Tympanostomy Tube Administration

NCT02350998

COMPLETED Phase 3

OTO-201 for the Treatment of Middle Ear Effusion in Pediatric Subjects Requiring Tympanostomy Tube Placement

NCT01949155

COMPLETED Phase 2

OTO-104 for the Treatment of Meniere's Disease

NCT01412177

COMPLETED Phase 3

OTO-201 for the Treatment of Middle Ear Effusion in Pediatric Subjects Requiring Tympanostomy Tube Placement

NCT01949142

COMPLETED Phase 1

OTO-201 for Middle Ear Effusion in Pediatric Subjects Requiring Tympanostomy Tube Placement

NCT01755286

COMPLETED Phase 1

OTO-104 for Meniere's Disease

NCT01084525

Phase Distribution

PhaseTrial count
Phase 1 4
Phase 2 6
Phase 3 10

How the Otonomy archive is shaped

20 indexed studies, none listed as recruiting (0% open); 16 completed (80%).

Phase mix: 10 late (III/IV) vs 10 early (I/II) (balanced across stages).

Top condition: Swimmer's Ear (1 trial), 4 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Otonomy: archived-pipeline peers nationwide

Peers matched on 20 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Otonomy sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0510152025 0%5%10%15%20% Total trials Recruiting share Otonomy59th Medical WingAbiomedAgency for Healthcare Research and Quality (AHRQ)Alliance Foundation Trials10xBio22nd Century Group23andMe3-C Institute for Social Development
Otonomy sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Otonomy sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 20 archived trials

Sponsors with similar archive density (± trial count)

What to do with this Otonomy page

20 registered trials is a research-attention snapshot, not an endorsement of Otonomy or any single study.

  • None of Otonomy's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Swimmer's Ear is the condition Otonomy studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Swimmer's Ear trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Otonomy pipeline card: 20 registered trials from official public datasets.Report a data error.